Publication:
Diabetic osteodystrophy

dc.contributor.authorEren, Mehmet Ali
dc.contributor.authorGül, Özen Öz
dc.contributor.buuauthorÖZ GÜL, ÖZEN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentEndokrinoloji Anabilim Dalı
dc.contributor.researcheridKXW-8889-2024
dc.date.accessioned2025-02-06T06:40:22Z
dc.date.available2025-02-06T06:40:22Z
dc.date.issued2024-07-01
dc.description.abstractDiabetes mellitus (DM) is associated with an increased risk of fractures due to deterioration of bone quality, which can be referred to as "diabetic osteodystrophy." Furthermore, the risk of fracture is increased in DM, even if bone mineral density is normal or high and is associated with increased morbidity if a fracture develops. In addition to the pathophysiological mechanisms of DM, diabetes- related complications and drugs used in the treatment of DM may also affect bone health. Moreover, the increased risk of falling due to microvascular complications, hypoglycemia, and postural hypotension also contributes to the development of fractures. Individuals with DM should be screened for osteoporosis with recommendations similar to those of the general population. When diagnosing osteoporosis and deciding on treatment, it should be kept in mind that DM may be an important risk factor, and lower threshold values of the T score should be used.
dc.identifier.doi10.5152/erp.2024.24463
dc.identifier.eissn2822-6135
dc.identifier.endpage180
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85199174325
dc.identifier.startpage175
dc.identifier.urihttps://doi.org/10.5152/erp.2024.24463
dc.identifier.urihttps://endocrinolrespract.org/en/diabetic-osteodystrophy-131225
dc.identifier.urihttps://hdl.handle.net/11452/50147
dc.identifier.volume28
dc.identifier.wos001267516900008
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves Yayıncılık
dc.relation.journalEndocrinology Research and Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBone-mineral density
dc.subjectDipeptidyl peptidase-4 inhibitors
dc.subjectGlycation end-products
dc.subjectInsulin-resistance
dc.subjectFracture risk
dc.subjectMetaanalysis
dc.subjectTurnover
dc.subjectAssociation
dc.subjectMellitus
dc.subjectDisease
dc.subjectDiabetes mellitus
dc.subjectFracture risk
dc.subjectOsteodystrophy
dc.subjectOsteoporosis
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectEndocrinology & metabolism
dc.titleDiabetic osteodystrophy
dc.typeReview
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Endokrinoloji Anabilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication4ebb27f5-06de-45b8-8773-ea3452507df3
relation.isAuthorOfPublication.latestForDiscovery4ebb27f5-06de-45b8-8773-ea3452507df3

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gul_Eren_2024.pdf
Size:
1008.49 KB
Format:
Adobe Portable Document Format